Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Febuxostat Krka, febuxostat, Date of authorisation: 28/03/2019, Revision: 7, Status: Authorised

Minutes of the COMP meeting 18-19 February 2025

Annex - National provisions for SMEs applicable to the pharmaceutical sector

Fields and business rules for the European Shortages Monitoring Platform (ESMP) API datasets

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Date of authorisation: 24/04/2023, Revision: 4, Status: Authorised

European Shortages Monitoring Platform (ESMP)

Fields and business rules for the European Shortages Monitoring Platform (ESMP) API datasets

European shortages monitoring platform (ESMP) API - Instructions to request access for national competent authorities (NCAs) and marketing authorisation holders (MAHs)